Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-17-013436)

Filing Details

Accession Number:: 0001225208-17-013436
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-09 17:00:31
Reporting Period:: 2017-08-07

Filing Date:: 2017-08-09
Accepted Time:: 2017-08-09 17:00:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1678459	R Alexander Mackenzie	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-08-07	3,000	$33.56	151,474	No	4	S	Direct
Common Stock	Disposition	2017-08-07	12,000	$33.49	139,474	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,796	Indirect	By Rule 16b-3 Plan

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2016.